Cargando…
Drug Repurposing Screening Identifies Novel Compounds That Effectively Inhibit Toxoplasma gondii Growth
The urgent need to develop new antimicrobial therapies has spawned the development of repurposing screens in which well-studied drugs and other types of compounds are tested for potential off-label uses. As a proof-of-principle screen to identify compounds effective against Toxoplasma gondii, we scr...
Autores principales: | Dittmar, Ashley J., Drozda, Allison A., Blader, Ira J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894684/ https://www.ncbi.nlm.nih.gov/pubmed/27303726 http://dx.doi.org/10.1128/mSphere.00042-15 |
Ejemplares similares
-
Forward Genetic Screening Identifies a Small Molecule That Blocks Toxoplasma gondii Growth by Inhibiting Both Host- and Parasite-Encoded Kinases
por: Brown, Kevin M., et al.
Publicado: (2014) -
The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis
por: Brown, Kevin M., et al.
Publicado: (2009) -
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against Toxoplasma gondii
por: Cajazeiro, Débora Chaves, et al.
Publicado: (2022) -
Screening of a library of traditional Chinese medicines to identify compounds
and extracts which inhibit Toxoplasma gondii growth
por: SAITO, Harunobu, et al.
Publicado: (2020) -
siRNA Screening Identifies the Host Hexokinase 2 (HK2) Gene as an Important Hypoxia-Inducible Transcription Factor 1 (HIF-1) Target Gene in Toxoplasma gondii-Infected Cells
por: Menendez, Matthew T., et al.
Publicado: (2015)